|
Volumn 37, Issue 4, 2006, Pages 329-331
|
Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment
c
Medical School
(Greece)
|
Author keywords
Hepatitis C; Pegylated interferon; Procalcitonin; Ribavirin
|
Indexed keywords
PEGINTERFERON ALPHA2B;
PROCALCITONIN;
RIBAVIRIN;
VIRUS RNA;
ADULT;
BACTERIAL INFECTION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HEPATITIS C;
HORMONE BLOOD LEVEL;
HUMAN;
LETTER;
LIVER CIRRHOSIS;
LIVER DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL PARAMETERS;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
STATISTICAL ANALYSIS;
TREATMENT RESPONSE;
VIROLOGY;
ADULT;
ANTIVIRAL AGENTS;
CALCITONIN;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGED;
POLYETHYLENE GLYCOLS;
PROTEIN PRECURSORS;
RIBAVIRIN;
|
EID: 33750523413
PISSN: 13866532
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcv.2006.08.014 Document Type: Letter |
Times cited : (6)
|
References (6)
|